TABLE 1.
Characteristics of the data sets
| Characteristic | Value or information for: |
||
|---|---|---|---|
| Data set 1 | Data set 2 | Data set 3 | |
| No. of isolates (n = 968) | 411 | 177 | 380 |
| Collection period | 2010–2015 | 2018 | 2010 and 2015 |
| Location | Toronto, Canada (city) | Toronto, Canada (city) | Southeastern Ontario, Canada |
| Location type | Hospital lab | Hospital lab | Hospital lab |
| Inpatient or outpatient | Inpatient | In- and outpatients | In- and outpatients |
| Anatomic site | Blood | Urine | Variable |
| Sampling bias | None | None | MDR |
| No. (%) of isolates susceptible to the following antibiotics: | |||
| Ciprofloxacin | 297 (72) | 120 (68) | 118 (31) |
| Ceftriaxone | 357 (87) | 155 (88) | 236 (62) |
| Gentamicin | 355 (86) | 156 (88) | 229 (60) |
| Trimethoprim-sulfamethoxazole | 292 (71) | 125 (71) | 79 (21) |
| Ertapenem | 410 (99) | 177 (100) | 338 (89) |
| No. (%) of isolates with the following predominant ST: | |||
| 1193 | 14 (3.4) | 15 (8.5) | 21 (5.5) |
| 127 | 15 (3.6) | 7 (4.0) | 3 (0.8) |
| 131 | 87 (21) | 36 (20) | 170 (45) |
| 38 | 7 (1.7) | 2 (1.1) | 12 (3.2) |
| 405 | 9 (2.2) | 1 (0.6) | 11 (2.9) |
| 648 | 6 (1.5) | 8 (4.5) | 17 (4.5) |
| 69 | 22 (5.4) | 13 (7.3) | 23 (6.1) |
| 73 | 57 (14) | 20 (11) | 20 (5.3) |
| 95 | 58 (14) | 19 (11) | 12 (3.2) |
| Other | 136 (33) | 56 (32) | 91 (24) |